07:00 , Mar 11, 2013 |  BC Week In Review  |  Company News

StableBody Technologie, Lurie Children's Hospital of Chicago deal

The research center granted protein engineering company StableBody an exclusive license to develop diagnostic and therapeutic cancer compounds targeting metabolic signaling pathways involved in tumor growth, metastasis and vasculogenic mimicry. The IP is also implicated...
08:00 , Jan 14, 2013 |  BC Week In Review  |  Company News

BGI, Children's Hospital of Philadelphia deal

BGI and the hospital said the BGI@CHOP Joint Genome Center will conduct research into next-generation sequencing and analysis of pediatric brain tumors. The research will support the Childhood Brain Tumor Tissue Consortium, which also includes...